Skip to main content

Table 2 Factors associated with outcomes among 637 subjects who did not complete screening and did not start antiretroviral therapy despite being eligible for treatment on clinical grounds

From: Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda

 

Died

On ART with another provider

Alive and not on ART

Lost to follow-up

p-value

 

(n. 181)

(n. 189)

(n. 158)

(n. 109)

 

Male, number (%)

68 (38)

65 (34)

47 (30)

31 (28)

0.3 *

Age ≤ 35 years, number (%)

81 (45)

91 (48)

72 (46)

63 (58)

0.15*

CD4 count × 106/l

     

   Median (IQR)

38 (8, 102)

105 (37, 162)

129 (77, 172)

67 (10, 127)

0.0001

   <50

104 (57)

53 (28)

25 (16)

50 (46)

< 0.0001 *

   50–99

30 (17)

37 (20)

29 (19)

18 (17)

 

   ≥100

47 (26)

99 (52)

104 (66)

41 (38)

 
  1. * chi-squared test
  2. † kruskall-wallis test